Bengaluru (Karnataka) [India], July 31 (ANI): Private equity major Tata Capital Growth Fund will pick up 0.85 per cent stake in the biologics arm of biopharmaceutical major Biocon for Rs 225 crore.
Bengaluru (Karnataka) [India], Jan 6 (ANI): Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.